SCHEMBL18376804

SCHEMBL18376804

CN1CCN(c2ccc(-c3cccc4cnc(Nc5ccc(OCCN6CCCC6)cc5)nc34)cc2)CC1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 5/20 0.57
BRD4 O60885 2/20 0.57
FGFR2 P21802 1/20 0.53
BRAF P15056 1/20 0.51
HRH3 Q9Y5N1 1/20 0.51
JAK3 P52333 4/20 0.50
PTK2 Q05397 2/20 0.50
FGFR1 P11362 2/20 0.49
SRC P12931 6/20 0.49
YES1 P07947 4/20 0.49
KDR P35968 3/20 0.49
EPHB4 P54760 3/20 0.49
ABL1 P00519 2/20 0.49
EGFR P00533 1/20 0.49
RAF1 P04049 1/20 0.49
LCK P06239 1/20 0.49
FYN P06241 1/20 0.49
LYN P07948 1/20 0.49
CYP3A4 P08684 1/20 0.49
PDGFRB P09619 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18377069 1.00 JAK2 (0.57) JAK2BRD4FGFR2BRAFHRH3
SCHEMBL29371925 0.91 BRAF (0.60) JAK2BRD4FGFR2BRAFHRH3
SCHEMBL18377066 0.91 BRAF (0.60) JAK2BRD4FGFR2BRAFHRH3
SCHEMBL18376789 0.89 BRAF (0.51) JAK2FGFR2BRAFHRH3JAK3
SCHEMBL18377042 0.88 BRAF (0.55) JAK2BRD4FGFR2BRAFJAK3
SCHEMBL29370829 0.88 BRAF (0.55) JAK2BRD4FGFR2BRAFJAK3
SCHEMBL16513615 0.88 MAPK10 (0.59) JAK2BRD4FGFR2BRAFJAK3
SCHEMBL18377046 0.86 BRD4 (0.63) JAK2BRD4JAK3KDREGFR
SCHEMBL18376830 0.85 JAK2 (0.68) JAK2BRD4FGFR2BRAFHRH3
SCHEMBL18376601 0.85 BRD4 (0.57) JAK2BRD4FGFR2JAK3FGFR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 CN claimed
CN-113999180-B Quinazoline compound, intermediate, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2024-03-26 CN disclosed
CN-113999180-A Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2022-02-01 CN disclosed
CN-106316965-B Quinazoline compound, intermediate thereof, preparation method, pharmaceutical composition and application 上海医药集团股份有限公司 2021-08-27 CN disclosed
WO-2017005137-A1 QUINAZOLINE COMPOUND, INTERMEDIATE, PREPARATION METHOD, PHARMACEUTICAL COMPOSITION AND USES THEREOF 吉林大学 2017-01-12 WO disclosed